Efficacy and safety of pyrotinib-containing regimen in the patients with HER2-positive metastatic breast cancer: A multicenter real-world study.

Sha Yin,Yajing Chi,Yangyang Du,Jingfen Wang,Changping Shan,Weiwei Yi,Mao Shang,Xiaochu Man,Qiaorui Tan,Huihui Li

Cancer medicine（2022）

引用 5|浏览1

暂无评分

摘要

Pyrotinib-containing regimen could effectively treat HER2-positive MBC with acceptable toxicity, including the patients who progressed after lapatinib treatment and with brain metastasis.

查看译文

关键词

HER2-positive breast cancer,efficacy,pyrotinib,real-world study,safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要